GOTHENBURG, Sweden, July 3, 2024 /PRNewswire/ — Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2024. The presentation will be held in English.
Time: Wednesday 17 July, 2024 at 10.00 a.m. CET.
To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group
Vitrolife Group participants:
Bronwyn Brophy O´Connor, CEO
Patrik Tolf, CFO
The press release for the interim report will be released at 8.00 CET on the same day.
Before the conference call, presentation material will be available at the company web page.
A recorded version of the telephone conference will be available for seven days on number +44 (0) 20 3451 9993 (International), access code 7692641#.
Gothenburg, 3 July 2024
VITROLIFE AB (publ)
Contact:
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/vitrolife-ab–publ-/r/conference-call-interim-report,c4010494
The following files are available for download:
Conference call interim report |
SOURCE Vitrolife AB (publ)
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…
Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology…
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:…
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical…
Highly experienced biotech executive and board member will assist Kalaris in achieving its next phase…
Al Zeyoudi: "Hosting such major international events reflects the UAE's pivotal role as a global…